Cytosol estrogen and progestin receptor concentrations and 17β‐hydroxysteroid dehydrogenase activities in the endometrium and endometriotic tissue
Authors:
- 11 January 1984
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 63 (S123) , 45-49
Abstract
Concentrations of cytosol estrogen (ERC) and progestin (PRc) receptors and the activities of 17β‐hydroxysteroid dehydrogenase (17‐HSD) were measured in 80 untreated and 23 danazol‐treated endometriotic tissue specimens. The results were compared with those obtained from endometrium specimens prior to or following danazol or medroxyprogesterone acetate (MPA) treatment. The concentrations of ERc and PRc in the endometriotic tissue were lower than corresponding values in the endometrium. Cytosol female sex steroid receptors were always present in the normal endometrium, whereas only 70% of the endometriotic lesions were simultaneously ERc‐and PRc‐positive (receptor concentration ≥3 and ≥6 fmol/mg cytosol protein respectively), 24% PRc‐positive, and 6% receptor‐negative. In the endometriotic tissue, the mean concentrations of PRc during the luteal phase of the cycle (90±23, SE, fmol/mg protein) were lower (p<0.05) than during the follicular phase (177±32 fmol/mg protein), while the ERc concentrations and 17‐HSD activities did not show any cyclic variations. Danazol and MPA had similar effects on the endometrium, both inducing a decrease in concentration of the female sex steroid receptors and an increase in activity of 17‐HSD during short‐term treatment (one week), and a decrease in activity of the enzyme during long‐term treatment (3 weeks). The effect of danazol on the endometriotic tissue differed from that found in the endometrium. Danazol did not alter the activity of 17‐HSD or the concentration of PRc but tended to increase the concentration of ERc in endometriotic tissue when given for 7–30 days. The present results suggest that endometriotic tissue is under the control of steroid hormones, but that this hormonal regulation does not seem to be identical with that found in the endometrium.Keywords
This publication has 19 references indexed in Scilit:
- Female sex steroid receptors in gynecological malignancies: Clinical correlatesJournal of Steroid Biochemistry, 1983
- Progestin-Like Effects of Danazol on Rabbit Uterus*Endocrinology, 1983
- Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17β-hydroxysteroid dehydrogenase activity, and serum hormone concentrationsAmerican Journal of Obstetrics and Gynecology, 1982
- Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal EndometriumNew England Journal of Medicine, 1981
- Danazol: Endocrine pharmacology and therapeutic applicationsAmerican Journal of Obstetrics and Gynecology, 1981
- Estrogen and progestin receptors in endometriosis lesions: Comparison with endometrial tissueAmerican Journal of Obstetrics and Gynecology, 1981
- Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: Therapeutic implicationsAmerican Journal of Obstetrics and Gynecology, 1981
- Determinations of Steroid Receptors and Their Clinical ApplicationsActa Obstetricia et Gynecologica Scandinavica, 1981
- Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administrationInternational Journal of Cancer, 1979
- Progestational activity of Danazol in the human female subjectAmerican Journal of Obstetrics and Gynecology, 1976